Optimization, Characteristics, and Functions of Alkaline Phosphatase From Escherichia coli

Yachao Dong, Yandong Xia, Jie Yin, Diao Zhou, Yidan Sang, Yan Sufeng, Qingshu Liu, Yaqi Li, Leli Wang, Ying Zhao, Cang Chen, Qiuyun Huang, Ying Wang, Muhammad Nazeer Abbasi, Huansheng Yang, Chunni Wang, Jianzhong Li, Qiang Tu, Jia YinFrontiers in Microbiology 2022 · DOI

TL;DR

This study engineered a highly active alkaline phosphatase (AKP) from E. coli and expressed it in B. subtilis to combat inflammation in piglet intestines caused by LPS. The optimized enzyme significantly reduced pro-inflammatory cytokine expression and improved intestinal barrier function in an in vitro model, offering a promising antibiotic alternative for sustainable pig farming.

What Problem Does This Paper Address?

Weaning piglets are susceptible to intestinal inflammation and disease, often triggered by Gram-negative bacteria like E. coli which produce lipopolysaccharide (LPS). LPS can initiate a cascade of inflammatory responses, leading to gut barrier disruption and reduced performance. While antibiotics have been a common solution, their restricted use due to resistance and adverse effects necessitates the development of effective alternatives. Alkaline phosphatase (AKP) is known to play a role in detoxifying LPS and mitigating inflammation, but its potential for industrial application requires optimization for higher activity and stability. This paper aims to engineer a more potent AKP and evaluate its protective effects on intestinal epithelial cells.

Methods

The researchers employed a multi-pronged approach:

  • Gene Engineering and Mutagenesis: They identified and cloned AKP genes from E. coli and other sources. Site-directed mutagenesis was used to create specific mutations in the enzyme's active site, aiming to enhance its activity. They also deleted the signal peptide to improve secretion.
  • Heterologous Expression: The engineered AKP genes were expressed in Bacillus subtilis, a generally recognized as safe (GRAS) bacterium known for its protein secretion capabilities and lack of endotoxins, making it a suitable host for industrial applications.
  • Enzyme Activity Assays: Standard biochemical assays were used to measure the activity of wild-type and mutant AKP enzymes under various conditions.
  • In Vitro Inflammation Model: An in vitro model using IPEC-J2 cells (porcine intestinal epithelial cells) was established. These cells were treated with LPS to induce an inflammatory response.
  • Gene Expression Analysis: Quantitative real-time PCR (qPCR) was used to measure the mRNA levels of key inflammatory cytokines (IL-6, IL-8, TNF-α) and tight junction proteins (ZO-1, CLDN-3) in the IPEC-J2 cells after treatment with LPS and the engineered AKP.
  • Protein Stability and Simulation: The thermal stability of the engineered AKP was tested, and molecular dynamics simulations were performed to understand the structural basis of its activity and stability.

Datasets

Not discussed in the paper. The study primarily relies on in vitro cell culture experiments and biochemical assays.

Key Insights and Ideas

  • Signal Peptide Deletion Boosts Activity: Removing the signal peptide from the E. coli AKP significantly increased its enzymatic activity, suggesting it was hindering secretion or proper folding.
  • Targeted Mutations Dramatically Enhance Potency: Specific amino acid substitutions (DelSigD153G-D330N) in the AKP enzyme led to a remarkable increase in activity, orders of magnitude higher than the wild-type. This highlights the power of rational protein engineering.
  • B. subtilis as an Ideal Expression Host: The study successfully leveraged B. subtilis's ability to secrete high levels of functional proteins without producing endotoxins, making it a superior platform for producing this engineered enzyme compared to E. coli.
  • AKP as a Dual-Action Agent: The engineered AKP not only detoxified LPS but also actively promoted the expression of tight junction proteins, reinforcing the intestinal barrier. This dual action is crucial for combating inflammation.
  • Thermostability for Industrial Processing: The engineered AKP demonstrated remarkable stability at high temperatures, making it suitable for industrial processes like spray drying, which is essential for feed additive formulation.

Key Results

  • The DelSigD153G-D330N mutant of AKP exhibited nearly 1,600 times higher activity than the wild-type E. coli AKP with a signal peptide.
  • In the LPS-induced IPEC-J2 cell model, treatment with the engineered AKP significantly downregulated the expression of pro-inflammatory cytokines IL-6, IL-8, and TNF-α.
  • Concurrently, the engineered AKP significantly upregulated the expression of tight junction proteins ZO-1 and CLDN-3, indicating improved intestinal barrier integrity.
  • The engineered AKP showed high thermal stability, retaining significant activity even after exposure to 120°C for 1 minute.

Limitations and Future Work

  • In Vitro to In Vivo Translation: While the in vitro results are promising, further studies are needed to validate the efficacy and safety of the engineered AKP in live animals, particularly weaned piglets.
  • Mechanism of Tight Junction Upregulation: The paper notes that the mechanism by which AKP increases tight junction protein expression in the presence of LPS is not fully elucidated, suggesting further investigation into adenosine signaling pathways.
  • Optimization of Production: While B. subtilis was used, further optimization of fermentation and purification processes may be required for cost-effective large-scale production.
  • Long-Term Effects and Dosage: The long-term effects of AKP supplementation and optimal dosage for different stages of piglet development warrant further research.

The authors express hope that this research will contribute to the sustainable development of the pig industry by providing a viable, antibiotic-free alternative for managing intestinal health.

Summary updated

Abstract

Weaning of piglets could increase the risk of infecting with Gram-negative pathogens, which can further bring about a wide array of virulence factors including the endotoxin lipopolysaccharide (LPS). It is in common practice that the use of antibiotics has been restricted in animal husbandry. Alkaline phosphatase (AKP) plays an important role in the detoxification and anti-inflammatory effects of LPS. This study investigated the protective effects of AKP on intestinal epithelial cells during inflammation. Site-directed mutagenesis was performed to modulate the AKP activity. The enzyme activity tests showed that the activity of the DelSigD<sub>153</sub>G-D<sub>330</sub>N mutants in <i>B. subtilis</i> was nearly 1,600 times higher than that of the wild-type AKP. In this study, an <i>in vitro</i> LPS-induced inflammation model using IPEC-J2 cells was established. The mRNA expression of interleukin-(IL-) 6, IL-8, and tumor necrosis factor-α (TNF-α) were extremely significantly downregulated, and that of ASC amino acid transporter 2 (ASCT-2), zonula occludens protein-1 (ZO-1), and occludin-3 (CLDN-3) were significantly upregulated by the DelSigD<sub>153</sub>G-D<sub>330</sub>N mutant compared with LPS treatment. This concludes the anti-inflammatory role of AKP on epithelial membrane, and we are hopeful that this research could achieve a sustainable development for the pig industry.
BibTeX
@inproceedings{dong2022optimization,
  author = {Yachao Dong and Yandong Xia and Jie Yin and Diao Zhou and Yidan Sang and Yan Sufeng and Qingshu Liu and Yaqi Li and Leli Wang and Ying Zhao and Cang Chen and Qiuyun Huang and Ying Wang and Muhammad Nazeer Abbasi and Huansheng Yang and Chunni Wang and Jianzhong Li and Qiang Tu and Jia Yin and Jia Yin and Jia Yin},
  title = {{Optimization, Characteristics, and Functions of Alkaline Phosphatase From Escherichia coli}},
  booktitle = {Frontiers in Microbiology},
  year = {2022},
  doi = {10.3389/fmicb.2021.761189},
}
Figure